Invention Grant
- Patent Title: Cancer-treating recombinant protein that improves the activity of cytotoxic killer cells targeting cancer cells and use thereof
-
Application No.: US16112826Application Date: 2018-08-27
-
Publication No.: US11440941B2Publication Date: 2022-09-13
- Inventor: Chang-Duk Jun , Bu Nam Jeon , Hey-Ran Kim
- Applicant: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Gwangju
- Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee: GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
- Current Assignee Address: KR Gwangju
- Agency: Brooks Kushman P.C.
- Priority: KR10-2018-0041625 20180410
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61P35/00 ; A61K35/17 ; C12N5/0783 ; A61K38/17
Abstract:
A cancer killer cell in which a therapeutic recombinant protein or recombinant protein which improves cytotoxic activity of the cancer killer cell is loaded. In addition, a pharmaceutical composition including the recombinant protein or a recombinant protein-loaded cancer killer cell is disclosed. Further, disclosed is a method for preparing a recombinant protein-loaded cancer killer cell.
Public/Granted literature
Information query
